Overview Fundamentals API Earnings EOD API Sample Code Pricing

LIPIGON PHARMA. AB (9RP F) stock market data APIs

€0.0122 0(0%) as of July 26, 2024
Price chart is built with Anychart

Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease; a gene therapy project for the treatment of the rare disease lipodystrophy; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia. The company was incorporated in 2010 and is based in Umeå, Sweden.

LIPIGON PHARMA. AB Financial Data Overview

0.0122
0.0122
-
0.0122
0.0122
0.0078-0.06
3 996 K
1.22
148 M
16 407 K
0.347
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '9RP',
Type: 'Common Stock',
Name: 'LIPIGON PHARMA. AB',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'SE0015382072',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

LIPIGON PHARMA. AB Fundamental Data is available in our Financial Data APIs

  • Net Revenue 16 407 K
  • EBITDA -14 268 000
  • Earnings Per Share 0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get LIPIGON PHARMA. AB Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get LIPIGON PHARMA. AB End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com